You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clinical stage III or resectable stage IV melanoma (MEL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

Not yet recruiting
  • Melanoma Stage III
  • Toripalimab combined with Temozolomide
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 23, 2023

Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma Stage III
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Participation Patterns Among Stage IV Melanoma Patients

Not yet recruiting
  • Stage IV Melanoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Amsterdam, NH, Netherlands
      Antoni van Leeuwenhoek ziekenhuis
    Feb 11, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    Dec 6, 2022

    Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

    Active, not recruiting
    • Metastatic Melanoma
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 13, 2023

    Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation Trial in Shanghai (Furmonertinib, Bevacizumab)

    Recruiting
    • Lung Adenocarcinoma Stage III
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Aug 13, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Stage IV Melanoma, Unresectable Stage III Cutaneous Melanoma Trial in Boston

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Sep 17, 2022

    Patients With Stage 0-IV Melanoma in Real Clinical Practice

    Recruiting
    • Melanoma
    • +7 more
    • surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
    • Moscow, Russian Federation
      N.N. Blokhin Russian Cancer Research Center
    Jun 12, 2022

    Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

    Active, not recruiting
    • Stage III Cutaneous Melanoma AJCC v7
    • +4 more
    • Cryosurgery
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Jan 3, 2023

    Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

    Not yet recruiting
    • Melanoma Stage IV
    • +3 more
    • (no location specified)
    Dec 14, 2022

    Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +9 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Oct 4, 2023

    Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

    Active, not recruiting
    • Melanoma Stage Iii
    • +4 more
    • Chapel Hill, North Carolina
      UNC Lineberger Comprehensive Cancer Center
    Jul 20, 2022

    Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

    Completed
    • Stage III Malignant Melanoma of Skin AJCC V6
    • Stage IV Malignant Melanoma of Skin
    • TAPCells vaccine
    • Santiago, RM, Chile
      Faculty of Medicine, University of Chile
    Nov 21, 2023

    Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

    Terminated
    • Recurrent Melanoma
    • +3 more
    • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
    • Laboratory Biomarker Analysis
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Melanoma Trial in East Melbourne, Heidelberg (NY-ESO-1 ISCOMATRIX® vaccine, Cyclophosphamide)

    Completed
    Has Results
    • Melanoma
    • East Melbourne, Victoria, Australia
    • +1 more
    Oct 3, 2022

    Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

    Recruiting
    • Melanoma Stage III
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 6, 2022

    Pathologic Stage III Cutaneous Melanoma AJCC v8 Trial in United States (Imprime PGG, Pembrolizumab)

    Withdrawn
    • Pathologic Stage III Cutaneous Melanoma AJCC v8
    • Imprime PGG
    • Pembrolizumab
    • La Jolla, California
    • +3 more
    Oct 29, 2021

    Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Dostarlimab (TSR-042) (singly)
    • Dostarlimab (TSR-042) and TSR-022 (combination)
    • Washington, District of Columbia
    • +2 more
    Feb 22, 2022

    Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

    Recruiting
    • Advanced Colorectal Carcinoma
    • +15 more
    • Fermented Wheat Germ Extract
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jul 26, 2023

    Improve Early Detection of Cancer Recurrence in High-Risk

    Recruiting
    • Stage III Melanoma
    • Stage IV Cutaneous Melanoma
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Oct 6, 2022

      Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

      Recruiting
      • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
      • +4 more
      • Cemiplimab
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 17, 2023

      Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +5 more
      • Jacksonville, Florida
      • +2 more
      Oct 21, 2022

      Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

      Not yet recruiting
      • Melanoma
      • Unresectable Melanoma
      • Los Angeles, California
      • +3 more
      Aug 4, 2022